Report Detail
Global Insulin Drug and Delivery Technologies Market Insights, Forecast to 2025
- RnM3536257 |
- 17 June, 2019 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
Insulin is a protein hormone that is used as a medication to treat high blood glucose. This includes in diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states. It is also used along with glucose to treat high blood potassium levels. Typically it is given by injection under the skin, but some forms may also be used by injection into a vein or muscle.
The emerging technologies in the insulin drug and delivery field have potential in the diabetes market, with improved glucose control, along with improved and well-accepted newer delivery methods. Modern industries and research institutes have begun to explore newer method for diabetes control in adults and juveniles, leading to a steady market for these technologies. Research and development (R&D) spending, increasing competition, patent expiries and emerging technologies are guiding this to a new direction. The new advancements, new product launches, and increased awareness and early detection of the disease have influenced the market to grow in the foreseeable future.
The global Insulin Drug and Delivery Technologies market is valued at 36000 million US$ in 2018 and will reach 67500 million US$ by the end of 2025, growing at a CAGR of 9.4% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Insulin Drug and Delivery Technologies market based on company, product type, end user and key regions.
This report studies the global market size of Insulin Drug and Delivery Technologies in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Insulin Drug and Delivery Technologies in these regions.
This research report categorizes the global Insulin Drug and Delivery Technologies market by top players/brands, region, type and end user. This report also studies the global Insulin Drug and Delivery Technologies market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sanofi
Eli Lilly and Company
Biocon
Julphar
Ypsomed
Becton, Dickinson and Company
Market size by Product
Insulin Syringes
Insulin Vials
Insulin Pens
Insulin Pumps
Market size by End User
Diabetes Mellitus Type 1
Diabetes Mellitus Type 2
Gestational Diabetes
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Insulin Drug and Delivery Technologies market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Insulin Drug and Delivery Technologies market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Insulin Drug and Delivery Technologies companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Insulin Drug and Delivery Technologies submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Insulin Drug and Delivery Technologies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Insulin Drug and Delivery Technologies market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Insulin Drug and Delivery Technologies Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Insulin Drug and Delivery Technologies Market Size Growth Rate by Product
- 1.4.2 Insulin Syringes
- 1.4.3 Insulin Vials
- 1.4.4 Insulin Pens
- 1.4.5 Insulin Pumps
- 1.5 Market by End User
- 1.5.1 Global Insulin Drug and Delivery Technologies Market Size Growth Rate by End User
- 1.5.2 Diabetes Mellitus Type 1
- 1.5.3 Diabetes Mellitus Type 2
- 1.5.4 Gestational Diabetes
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Insulin Drug and Delivery Technologies Market Size
- 2.1.1 Global Insulin Drug and Delivery Technologies Revenue 2014-2025
- 2.1.2 Global Insulin Drug and Delivery Technologies Sales 2014-2025
- 2.2 Insulin Drug and Delivery Technologies Growth Rate by Regions
- 2.2.1 Global Insulin Drug and Delivery Technologies Sales by Regions
- 2.2.2 Global Insulin Drug and Delivery Technologies Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Insulin Drug and Delivery Technologies Sales by Manufacturers
- 3.1.1 Insulin Drug and Delivery Technologies Sales by Manufacturers
- 3.1.2 Insulin Drug and Delivery Technologies Sales Market Share by Manufacturers
- 3.1.3 Global Insulin Drug and Delivery Technologies Market Concentration Ratio (CR5 and HHI)
- 3.2 Insulin Drug and Delivery Technologies Revenue by Manufacturers
- 3.2.1 Insulin Drug and Delivery Technologies Revenue by Manufacturers (2014-2019)
- 3.2.2 Insulin Drug and Delivery Technologies Revenue Share by Manufacturers (2014-2019)
- 3.3 Insulin Drug and Delivery Technologies Price by Manufacturers
- 3.4 Insulin Drug and Delivery Technologies Manufacturing Base Distribution, Product Types
- 3.4.1 Insulin Drug and Delivery Technologies Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Insulin Drug and Delivery Technologies Product Type
- 3.4.3 Date of International Manufacturers Enter into Insulin Drug and Delivery Technologies Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Insulin Drug and Delivery Technologies Sales by Product
- 4.2 Global Insulin Drug and Delivery Technologies Revenue by Product
- 4.3 Insulin Drug and Delivery Technologies Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Insulin Drug and Delivery Technologies Breakdown Data by End User
6 North America
- 6.1 North America Insulin Drug and Delivery Technologies by Countries
- 6.1.1 North America Insulin Drug and Delivery Technologies Sales by Countries
- 6.1.2 North America Insulin Drug and Delivery Technologies Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Insulin Drug and Delivery Technologies by Product
- 6.3 North America Insulin Drug and Delivery Technologies by End User
7 Europe
- 7.1 Europe Insulin Drug and Delivery Technologies by Countries
- 7.1.1 Europe Insulin Drug and Delivery Technologies Sales by Countries
- 7.1.2 Europe Insulin Drug and Delivery Technologies Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Insulin Drug and Delivery Technologies by Product
- 7.3 Europe Insulin Drug and Delivery Technologies by End User
8 Asia Pacific
- 8.1 Asia Pacific Insulin Drug and Delivery Technologies by Countries
- 8.1.1 Asia Pacific Insulin Drug and Delivery Technologies Sales by Countries
- 8.1.2 Asia Pacific Insulin Drug and Delivery Technologies Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Insulin Drug and Delivery Technologies by Product
- 8.3 Asia Pacific Insulin Drug and Delivery Technologies by End User
9 Central & South America
- 9.1 Central & South America Insulin Drug and Delivery Technologies by Countries
- 9.1.1 Central & South America Insulin Drug and Delivery Technologies Sales by Countries
- 9.1.2 Central & South America Insulin Drug and Delivery Technologies Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Insulin Drug and Delivery Technologies by Product
- 9.3 Central & South America Insulin Drug and Delivery Technologies by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Insulin Drug and Delivery Technologies by Countries
- 10.1.1 Middle East and Africa Insulin Drug and Delivery Technologies Sales by Countries
- 10.1.2 Middle East and Africa Insulin Drug and Delivery Technologies Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Insulin Drug and Delivery Technologies by Product
- 10.3 Middle East and Africa Insulin Drug and Delivery Technologies by End User
11 Company Profiles
- 11.1 Sanofi
- 11.1.1 Sanofi Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Sanofi Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Sanofi Insulin Drug and Delivery Technologies Products Offered
- 11.1.5 Sanofi Recent Development
- 11.2 Eli Lilly and Company
- 11.2.1 Eli Lilly and Company Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Eli Lilly and Company Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Eli Lilly and Company Insulin Drug and Delivery Technologies Products Offered
- 11.2.5 Eli Lilly and Company Recent Development
- 11.3 Biocon
- 11.3.1 Biocon Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Biocon Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Biocon Insulin Drug and Delivery Technologies Products Offered
- 11.3.5 Biocon Recent Development
- 11.4 Julphar
- 11.4.1 Julphar Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Julphar Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Julphar Insulin Drug and Delivery Technologies Products Offered
- 11.4.5 Julphar Recent Development
- 11.5 Ypsomed
- 11.5.1 Ypsomed Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Ypsomed Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Ypsomed Insulin Drug and Delivery Technologies Products Offered
- 11.5.5 Ypsomed Recent Development
- 11.6 Becton, Dickinson and Company
- 11.6.1 Becton, Dickinson and Company Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Becton, Dickinson and Company Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Becton, Dickinson and Company Insulin Drug and Delivery Technologies Products Offered
- 11.6.5 Becton, Dickinson and Company Recent Development
12 Future Forecast
- 12.1 Insulin Drug and Delivery Technologies Market Forecast by Regions
- 12.1.1 Global Insulin Drug and Delivery Technologies Sales Forecast by Regions 2019-2025
- 12.1.2 Global Insulin Drug and Delivery Technologies Revenue Forecast by Regions 2019-2025
- 12.2 Insulin Drug and Delivery Technologies Market Forecast by Product
- 12.2.1 Global Insulin Drug and Delivery Technologies Sales Forecast by Product 2019-2025
- 12.2.2 Global Insulin Drug and Delivery Technologies Revenue Forecast by Product 2019-2025
- 12.3 Insulin Drug and Delivery Technologies Market Forecast by End User
- 12.4 North America Insulin Drug and Delivery Technologies Forecast
- 12.5 Europe Insulin Drug and Delivery Technologies Forecast
- 12.6 Asia Pacific Insulin Drug and Delivery Technologies Forecast
- 12.7 Central & South America Insulin Drug and Delivery Technologies Forecast
- 12.8 Middle East and Africa Insulin Drug and Delivery Technologies Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Insulin Drug and Delivery Technologies Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Insulin Drug and Delivery Technologies . Industry analysis & Market Report on Insulin Drug and Delivery Technologies is a syndicated market report, published as Global Insulin Drug and Delivery Technologies Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Insulin Drug and Delivery Technologies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
